Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00962962 · ClinicalTrials.gov registry record · NA

Exercise Dose-Response Effects in Prediabetes

A NA study of PreDiabetes, sponsored by Duke University.

Completed
Registry status
NA
Development phase
288
Enrollment target
1
Study location

NCT00962962: Completed NA study of PreDiabetes, sponsored by Duke University.

NCT00962962 is a NA study of PreDiabetes that has completed, run by Duke University. The registered enrollment target is 288 participants, below the 700-participant average among 149 other PreDiabetes trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00962962, a NA study of PreDiabetes, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
288 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to evaluate the effects of different amounts and intensities of aerobic exercise training programs, with and without weight loss, in people who are at risk for diabetes. An additional purpose of the study is to evaluate the factors in the blood and in exercising muscles that contribute to the improvement in those risk factors. This information will be used to improve exercise training guidelines for improving cardiovascular and metabolic health in people with abnormal fasting glucose, also known as prediabetes.

Conditions Studied

Interventions

  • BEHAVIORAL Aerobic Exercise
  • BEHAVIORAL Exercise and Diet

Study Locations (1)

North Carolina

  • Duke Center For Living - Durham

Trial Details

FieldValue
Enrollment Target 288 participants
Start Date 2009-07
Est. Completion 2013-08
Phase NA
Duke University

1,725 total trials

What the finished NCT00962962 record still lists

NCT00962962 is an interventional study that assigns participants to a tested intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap, below the 700-participant average among 149 other PreDiabetes trials with a reported enrollment target (59% lower).

The record links to 1 condition, with PreDiabetes appearing as the primary indexed condition, and to 2 interventions - of which Aerobic Exercise is the first listed.

NCT00962962 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT00962962 about?

NCT00962962 is a clinical study titled "Exercise Dose-Response Effects in Prediabetes". The purpose of the study is to evaluate the effects of different amounts and intensities of aerobic exercise training programs, with and without weight loss, in people who are at risk for diabetes. An additional purpose of the study is to evaluate the factors in the blood and in exercising muscles t...

What is the current status of trial NCT00962962?

This trial is currently completed. It is a NA study. The enrollment target is 288 participants. The study started on 2009-07. Estimated completion is 2013-08.

What conditions does trial NCT00962962 study?

This clinical trial studies the following conditions: PreDiabetes.

What interventions are being tested in trial NCT00962962?

The interventions under investigation include: Aerobic Exercise (BEHAVIORAL), Exercise and Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT00962962?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00962962 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PreDiabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00962962's enrollment target sits among peer trials

288 31st of 149 higher than 119 of 149 other PreDiabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02098265 · 288 participants · NA

    A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device

  • NCT03741777 · 288 participants · NA

    Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume

  • NCT03937635 · 288 participants · Phase 3

    Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

  • NCT04621877 · 288 participants · NA

    Lay-Delivered Behavioral Activation in Senior Centers

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00962962, the US trial registry maintained by the National Library of Medicine. NCT00962962 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.